免疫調節剤の世界市場分析:製品別(免疫抑制剤、免疫刺激剤、ワクチン、抗体)、用途別(腫瘍学、呼吸器、HIV)、地域別、セグメント予測、2014-2025

調査会社Grand View Research社が発行したリサーチレポート(データ管理コード:GVIEW707423)
◆英語タイトル:Immunomodulators Market Analysis By Product (Immunosuppressant, Immunostimulants, Vaccines, Antibodies), By Application (Oncology, Respiratory, HIV), By Region, And Segment Forecasts, 2014-2025
◆発行会社/調査会社:Grand View Research
◆商品コード:GVIEW707423
◆発行日:2016年12月7日
◆調査対象地域:グローバル
◆産業分野:医療
◆ページ数:101
◆レポート言語:英語
◆レポート形式:PDF
◆納品方式:Eメール
◆販売価格オプション(消費税別)
Single UserUSD4,950 ⇒換算¥519,750見積依頼/購入/質問フォーム
Multi UserUSD7,950 ⇒換算¥834,750見積依頼/購入/質問フォーム
Global/corporate LicenseUSD9,950 ⇒換算¥1,044,750見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
Grand View Research社の概要及び新刊レポートはこちらでご確認いただけます。

★グローバルリサーチ資料[免疫調節剤の世界市場分析:製品別(免疫抑制剤、免疫刺激剤、ワクチン、抗体)、用途別(腫瘍学、呼吸器、HIV)、地域別、セグメント予測、2014-2025]についてメールでお問い合わせはこちら
本調査レポートでは、免疫調節剤の世界市場について調査・分析し、免疫調節剤の世界市場動向、免疫調節剤の世界市場規模、市場予測、セグメント別免疫調節剤市場分析、主要地域別市場規模、競争状況、関連企業情報などを含め、以下の構成でお届け致します。
*** レポート概要(サマリー)***

The global immunomodulators market is expected to reach USD 233.7 billion by 2025, according to a new study by Grand View Research, Inc. The market is anticipated to be predominantly driven by high R&D investments employed by the prominent companies, resulting into the large-scale production of new and therapeutically advanced drugs. This is believed to widen the influx of drugs at an unprecedented rate into the immunomodulators market hence providing highly efficacious treatment alternatives for numerous autoimmune and inflammatory diseases.
In addition, increasing drugs resistance is predicted to be responsible for boosting the clinical urgency to develop potentially new generation immunomodulators with targeted therapy mechanisms. The aforementioned factors cumulatively are expected to present significant growth opportunities over the forecast period.

Furthermore, burgeoning presence of the key players is expected to promote the awareness levels pertaining to benefits of immunomodulators amongst the patients as well as the physicians. This is further expected to widen the immunomodulators industry growth potential during the forecast period.

In addition, increasing adoption of monoclonal antibodies for a wide range of indications, such as, multiple sclerosis, Crohn’s disease, rheumatoid arthritis, and Non-Hodgkin’s Lymphoma, which is expected to boost immunomodulators industry over the forecast period. The consistent number of product approvals of highly significant monoclonal antibodies in autoimmune diseases is predicted to be responsible for widening the scope of growth.

Further Key Findings From the Study Suggest:

Immunosuppressant held the largest share of the product segment in 2015, owing to increasing number of transplantation procedures and need to prevent organ rejection

Antibodies held the dominant share of immunosuppressant in 2015, owing to extensive utilization in kidney, liver, heart, and lung transplants resulting in greater revenue generation

Immunostimulants expected to grow lucratively as a result of lower influx of immunostimulant generics for application in HIV, cancer and multiple sclerosis

In 2015, North America dominated the global immunomodulators market owing to presence of wide number of established pharmaceutical companies involved in extensive commercialization

The prominent participants are undertaking research and clinical collaborative strategies to yield new drugs and thereby to gain competitive advantage

For instance, in March 2015, Novartis AG entered into research collaboration with Aduro Biotech. This was carried out to enhance its next generation cancer immunotherapy product pipeline

*** レポート目次(コンテンツ)***

Table of Content

Chapter 1 Research Methodology & Scope
1.1 Region Wise Market Calculation
1.1.1 Region Wise Market: Base Estimates
1.1.2 Global Market: CAGR Calculation
1.2 Region-based segment share calculation
1.3 List of Secondary Sources
Chapter 2 Executive Summary
2.1 Market Snapshot
Chapter 3 Immunomodulators Market Variables, Trends & Scope
3.1 Market segmentation & scope
3.1.1 Market Driver Analysis
3.1.1.1 Increasing adoption of monoclonal antibodies
3.1.1.2 Rising incidence of cancer and other chronic conditions
3.1.1.3 Presence of strong pipeline portfolio
3.1.2 Market Restraint Analysis
3.1.2.1 High number of patent expiration
3.1.2.2 Growing generic & biosimilars competition
3.2 Penetration & Growth Prospect Mapping
3.3 Immunomodulators – PESTLE Analysis
3.4 Industry Analysis – Porter’s
Chapter 4 Immunomodulators Product Estimates & Trend Analysis
4.1 Immunomodulators Market: Product Movement Analysis
4.2 Immunosuppressants
4.2.1 Immunosuppressants market, 2014 – 2025 (USD Billion)
4.2.2 Antibodies
4.2.2.1 Antibodies market, 2014 – 2025 (USD Billion)
4.2.3 Calcineurin inhibitors
4.2.3.1 Calcineurin inhibitors market, 2014 – 2025 (USD Billion)
4.2.4 Glucocorticoid
4.2.4.1 Antimetabolites market, 2014 – 2025 (USD Billion)
4.2.5 Antimetabolites
4.2.5.1 Antimetabolites market, 2014 – 2025 (USD Billion)
4.2.6 Others
4.2.6.1 Others market, 2014 – 2025 (USD Billion)
4.3 Immunostimulants
4.3.1 Immunostimulants market, 2014 – 2025 (USD Billion)
4.3.2 Vaccines
4.3.2.1 Vaccines market, 2014 – 2025 (USD Billion)
4.3.3 Antibodies
4.3.3.1 Antibodies market, 2014 – 2025 (USD Billion)
4.3.4 Others
4.3.4.1 Others market, 2014 – 2025 (USD Billion)
Chapter 5 Immunomodulators Application Estimates & Trend Analysis
5.1 Immunomodulators Market: Application Movement Analysis
5.2 Oncology
5.2.1 Oncology s market, 2014 – 2025 (USD Billion)
5.3 Respiratory
5.3.1 Respiratory market, 2014 – 2025 (USD Billion)
5.4 HIV
5.4.1 HIV market, 2014 – 2025 (USD Billion)
5.5 Others
5.5.1 Others market, 2014 – 2025 (USD Billion)
Chapter 6 Immunomodulators Regional Estimates & Trend Analysis, by Product and Applications
6.1 Immunomodulators market share by region, 2015 & 2024
6.2 North America
6.2.1 North America immunomodulators market, 2014 – 2025 (USD Billion)
6.2.2 U.S.
6.2.2.1 U.S. immunomodulators market, 2014 – 2025 (USD Billion)
6.2.3 Canada
6.2.3.1 Canada Immunomodulators market, 2014 – 2025 (USD Billion)
6.3 Europe
6.3.1 Europe Immunomodulators market, 2014 – 2025 (USD Billion)
6.3.2 UK
6.3.2.1 UK Immunomodulators market, 2014 – 2025 (USD Billion)
6.3.3 Germany
6.3.3.1 Germany Immunomodulators market, 2014 – 2025 (USD Billion)
6.4 Asia Pacific
6.4.1 Asia Pacific Immunomodulators market, 2014 – 2025 (USD Billion)
6.4.2 Japan
6.4.2.1 Japan Immunomodulators market, 2014 – 2025 (USD Billion)
6.4.3 China
6.4.3.1 China Immunomodulators market, 2014 – 2025 (USD Billion)
6.4.4 India
6.4.4.1 India Immunomodulators market, 2014 – 2025 (USD Billion)
6.5 Latin America
6.5.1 Latin America Immunomodulators market, 2014 – 2025 (USD Billion)
6.5.2 Brazil
6.5.2.1 Brazil Immunomodulators market, 2014 – 2025 (USD Billion)
6.5.3 Mexico
6.5.3.1 Mexico Immunomodulators market, 2014 – 2025 (USD Billion)
6.6 MEA
6.6.1 MEA Immunomodulators market, 2014 – 2025 (USD Billion)
6.6.2 South Africa
6.6.2.1 South Africa Immunomodulators market, 2014 – 2025 (USD Billion)
Chapter 7 Competitive Landscape
7.1 Strategy framework
7.2 Market participation categorization
7.3 Company Profiles
7.3.1 F. Hoffmann-La Roche Ltd.
7.3.1.1 Company Overview
7.3.1.2 Financial Performance
7.3.1.3 Product Benchmarking
7.3.1.4 Strategic Initiatives
7.3.2 Amgen, Inc.
7.3.2.1 Company Overview
7.3.2.2 Financial Performance
7.3.2.3 Product Benchmarking
7.3.2.4 Strategic Initiatives
7.3.3 Abbott
7.3.3.1 Company Overview
7.3.3.2 Financial Performance
7.3.3.3 ProductBenchmarking
7.3.3.4 Strategic Initiatives
7.3.4 Johnson & Johnson
7.3.4.1 Company Overview
7.3.4.2 Financial Performance
7.3.4.3 Product Benchmarking
7.3.4.4 Strategic Initiatives
7.3.5 Novartis AG
7.3.5.1 Company Overview
7.3.5.2 Financial Performance
7.3.5.3 Product Benchmarking
7.3.5.4 Strategic Initiatives
7.3.6 Eli Lilly and Company
7.3.6.1 Company Overview
7.3.6.2 Financial Performance
7.3.6.3 Product Benchmarking
7.3.7 Bristol-Myers Squibb Company
7.3.7.1 Company Overview
7.3.7.2 Financial Performance
7.3.7.3 Product Benchmarking
7.3.7.4 Strategic Initiatives
7.3.8 Merck & Co., Inc.
7.3.8.1 Company Overview
7.3.8.2 Financial Performance
7.3.8.3 Product Benchmarking
7.3.8.4 Strategic Initiatives
7.3.9 Biogen
7.3.9.1 Company Overview
7.3.9.2 Financial Performance
7.3.9.3 Product Benchmarking
7.3.9.4 Strategic Initiatives

List of Figures

FIG. 1 Market summary
FIG. 2 Market trends & outlook
FIG. 3 Market segmentation & scope
FIG. 4 Market driver relevance analysis (Current & future impact)
FIG. 5 Market restraint relevance analysis (Current & future impact)
FIG. 6 Penetration & Growth Prospect Mapping
FIG. 7 Immunomodulators PESTLE Analysis
FIG. 8 Porter’s Five Forces Analysis
FIG. 9 Immunomodulators market product outlook key takeaways
FIG. 10 Immunomodulators market: Drug class movement analysis
FIG. 11 Immunosuppressants market, 2014 - 2025 (USD Billion)
FIG. 12 Antibodies market, 2014 - 2025 (USD Billion)
FIG. 13 Calcineurin inhibitors market, 2014 - 2025 (USD Billion)
FIG. 14 Glucocorticoid market, 2014 - 2025 (USD Billion)
FIG. 15 Antimetabolites market, 2014 - 2025 (USD Billion)
FIG. 16 Others market, 2014 - 2025 (USD Billion)
FIG. 17 Immunostimulants market, 2014 - 2025 (USD Billion)
FIG. 18 Vaccines market, 2014 - 2025 (USD Billion)
FIG. 19 Antibodies market, 2014 - 2025 (USD Billion)
FIG. 20 Others market, 2014 - 2025 (USD Billion)
FIG. 21 Immunomodulators market application outlook key takeaways
FIG. 22 Immunomodulators market: Indications movement analysis
FIG. 23 Oncology market, 2014 - 2025 (USD Billion)
FIG. 24 Respiratory market, 2014 - 2025 (USD Billion)
FIG. 25 HIV market, 2014 - 2025 (USD Billion)
FIG. 26 Others market, 2014 - 2025 (USD Billion)
FIG. 27 Regional marketplace: Key takeaways
FIG. 28 Regional outlook, 2015 & 2024
FIG. 29 North America immunomodulators market, 2014 - 2025 (USD Billion)
FIG. 30 U.S. immunomodulators market, 2014 - 2025 (USD Billion)
FIG. 31 Canada Immunomodulators market, 2014 - 2025 (USD Billion)
FIG. 32 Europe Immunomodulators market, 2014 - 2025 (USD Billion)
FIG. 33 UK Immunomodulators market, 2014 - 2025 (USD Billion)
FIG. 34 Germany Immunomodulators market, 2014 - 2025 (USD Billion)
FIG. 35 Asia Pacific Immunomodulators market, 2014 - 2025 (USD Billion)
FIG. 36 Japan Immunomodulators market, 2014 - 2025 (USD Billion)
FIG. 37 China Immunomodulators market, 2014 - 2025 (USD Billion)
FIG. 38 India Immunomodulators market, 2014 - 2025 (USD Billion)
FIG. 39 Latin America Immunomodulators market, 2014 - 2025 (USD Billion)
FIG. 40 Brazil Immunomodulators market, 2014 - 2025 (USD Billion)
FIG. 41 Mexico Immunomodulators market, 2014 - 2025 (USD Billion)
FIG. 42 MEA Immunomodulators market, 2014 - 2025 (USD Billion)
FIG. 43 South Africa Immunomodulators market, 2014 - 2025 (USD Billion)
FIG. 44 Strategy framework
FIG. 45 Participant categorization

List of Tables

TABLE 1 North America immunomodulators market, by product, 2014 - 2025 (USD Billion)
TABLE 2 North America immunosuppressants market, by type, 2014 - 2025 (USD Billion)
TABLE 3 North America immunostimulants market, by type, 2014 - 2025 (USD Billion)
TABLE 4 North America immunomodulators market, by applications, 2014 - 2025 (USD Billion)
TABLE 5 U.S. immunomodulators market, by product, 2014 - 2025 (USD Billion)
TABLE 6 U.S. immunosuppressants market, by type, 2014 - 2025 (USD Billion)
TABLE 7 U.S. immunostimulants market, by type, 2014 - 2025 (USD Billion)
TABLE 8 U.S. immunomodulators market, by applications, 2014 - 2025 (USD Billion)
TABLE 9 Canada immunomodulators market, by product, 2014 - 2025 (USD Billion)
TABLE 10 Canada immunosuppressants market, by type, 2014 - 2025 (USD Billion)
TABLE 11 Canada immunostimulants market, by type, 2014 - 2025 (USD Billion)
TABLE 12 Canada immunomodulators market, by applications, 2014 - 2025 (USD Billion)
TABLE 13 Europe immunomodulators market, by product, 2014 - 2025 (USD Billion)
TABLE 14 Europe immunosuppressants market, by type, 2014 - 2025 (USD Billion)
TABLE 15 Europe immunostimulants market, by type, 2014 - 2025 (USD Billion)
TABLE 16 Europe immunomodulators market, by applications, 2014 - 2025 (USD Billion)
TABLE 17 UK immunomodulators market, by product, 2014 - 2025 (USD Billion)
TABLE 18 UK immunosuppressants market, by type, 2014 - 2025 (USD Billion)
TABLE 19 UK immunostimulants market, by type, 2014 - 2025 (USD Billion)
TABLE 20 UK immunomodulators market, by applications, 2014 - 2025 (USD Billion)
TABLE 21 Germany immunomodulators market, by product, 2014 - 2025 (USD Billion)
TABLE 22 Germany immunosuppressants market, by type, 2014 - 2025 (USD Billion)
TABLE 23 Germany immunostimulants market, by type, 2014 - 2025 (USD Billion)
TABLE 24 Germany immunomodulators market, by applications, 2014 - 2025 (USD Billion)
TABLE 25 Asia Pacific immunomodulators market, by product, 2014 - 2025 (USD Billion)
TABLE 26 Asia Pacific immunosuppressants market, by type, 2014 - 2025 (USD Billion)
TABLE 27 Asia Pacific immunostimulants market, by type, 2014 - 2025 (USD Billion)
TABLE 28 Asia Pacific immunomodulators market, by applications, 2014 - 2025 (USD Billion)
TABLE 29 Japan immunomodulators market, by product, 2014 - 2025 (USD Billion)
TABLE 30 Japan immunosuppressants market, by type, 2014 - 2025 (USD Billion)
TABLE 31 Japan immunostimulants market, by type, 2014 - 2025 (USD Billion)
TABLE 32 Japan immunomodulators market, by applications, 2014 - 2025 (USD Billion)
TABLE 33 China immunomodulators market, by product, 2014 - 2025 (USD Billion)
TABLE 34 China immunosuppressants market, by type, 2014 - 2025 (USD Billion)
TABLE 35 China immunostimulants market, by type, 2014 - 2025 (USD Billion)
TABLE 36 China immunomodulators market, by applications, 2014 - 2025 (USD Billion)
TABLE 37 India immunomodulators market, by product, 2014 - 2025 (USD Billion)
TABLE 38 India immunosuppressants market, by type, 2014 - 2025 (USD Billion)
TABLE 39 India immunostimulants market, by type, 2014 - 2025 (USD Billion)
TABLE 40 India immunomodulators market, by applications, 2014 - 2025 (USD Billion)
TABLE 41 Latin America immunomodulators market, by product, 2014 - 2025 (USD Billion)
TABLE 42 Latin America immunosuppressants market, by type, 2014 - 2025 (USD Billion)
TABLE 43 Latin America immunostimulants market, by type, 2014 - 2025 (USD Billion)
TABLE 44 Latin America immunomodulators market, by applications, 2014 - 2025 (USD Billion)
TABLE 45 Brazil immunomodulators market, by product, 2014 - 2025 (USD Billion)
TABLE 46 Brazil immunosuppressants market, by type, 2014 - 2025 (USD Billion)
TABLE 47 Brazil immunostimulants market, by type, 2014 - 2025 (USD Billion)
TABLE 48 Brazil immunomodulators market, by applications, 2014 - 2025 (USD Billion)
TABLE 49 Mexico immunomodulators market, by product, 2014 - 2025 (USD Billion)
TABLE 50 Mexico immunosuppressants market, by type, 2014 - 2025 (USD Billion)
TABLE 51 Mexico immunostimulants market, by type, 2014 - 2025 (USD Billion)
TABLE 52 Mexico immunomodulators market, by applications, 2014 - 2025 (USD Billion)
TABLE 53 MEA immunomodulators market, by product, 2014 - 2025 (USD Billion)
TABLE 54 MEA immunosuppressants market, by type, 2014 - 2025 (USD Billion)
TABLE 55 MEA immunostimulants market, by type, 2014 - 2025 (USD Billion)
TABLE 56 MEA immunomodulators market, by applications, 2014 - 2025 (USD Billion)
TABLE 57 South Africa immunomodulators market, by product, 2014 - 2025 (USD Billion)
TABLE 58 South Africa immunosuppressants market, by type, 2014 - 2025 (USD Billion)
TABLE 59 South Africa immunostimulants market, by type, 2014 - 2025 (USD Billion)
TABLE 60 South Africa immunomodulators market, by applications, 2014 - 2025 (USD Billion)

*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/


※おすすめ調査資料
  • 世界の次世代型ネブライザー市場予測 2020年-2025年
    According to this study, over the next five years the Next Generation Nebulizer market will register a xx% CAGR in terms of revenue, the global market size will reach $ xx million by 2025, from $ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of k …
  • 世界の硫化アルミニウム市場2017
    Notes:Sales, means the sales volume of Aluminum Sulfide Revenue, means the sales value of Aluminum Sulfide This report studies sales (consumption) of Aluminum Sulfide in Global market, especially in United States, China, Europe and Japan, focuses on top players in these regions/countries, with sales …
  • 殺鼠剤の世界市場予測:種類別(非抗凝固剤、抗凝固剤(FGAR、SGAR))、エンドユース別(農業分野、倉庫、家庭、商業)、適用モード別(ペレット、スプレー、パウダー)、齧歯類別、地域別
    “Rising urbanization is causing displacement of rodents which is driving the rodenticides market”. The global rodenticides market size is estimated to be valued at USD 4.9billion in 2020 and is projected to reach USD 6.6billion by 2026, recording a CAGR of 5.0%. The increase in demand for rodent pes …
  • ガスセンサーの世界市場展望2018-2027
    According to Stratistics MRC, the Global Gas Sensors Market accounted for $0.93 billion in 2018 and is expected to reach $1.93 billion by 2027 growing at a CAGR of 8.5% during the forecast period. Increasing industrial gas induced accidents, necessity to continually monitor and control the gases use …
  • スチールアルミニウム製ドア及び窓の世界及び中国市場 2018年
    The 'Global and Chinese Steel Aluminum Doors and Windows Industry, 2013-2023 Market Research Report' is a professional and in-depth study on the current state of the global Steel Aluminum Doors and Windows industry with a focus on the Chinese market. The report provides key statistics on the market …
  • 温水ヒータの世界市場
    In this report, the global Water Heaters market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report is segmented into several key Regions, with production, consumption, revenue (mi …
  • 台湾の無水酢酸市場(~2019):市場規模、シェア、動向
    Acetic Anhydride Industry Outlook in Taiwan to 2019 - Market Size, Price Trends and Trade Balance Summary GlobalData’s new report, "Acetic Anhydride Industry Outlook in Taiwan to 2019 - Market Size, Price Trends and Trade Balance", provides in-depth coverage of Taiwan’s Acetic Anhydride industry and …
  • 飼料用酸味料の世界市場2017-2026
    According to Stratistics MRC, the Global Feed Acidifiers Market is accounted for $2.89 billion in 2017 and is expected to reach $5.35 billion by 2026 growing at a CAGR of 7.1% during the forecast period. Some of the key factors propelling the market growth are growing consumption of meat and dairy p …
  • デジタル物流の世界市場
    Digital Logistics market worldwide is projected to grow by US$8 Billion, driven by a compounded growth of 7. 8%. Tracking & Monitoring Systems, one of the segments analyzed and sized in this study, displays the potential to grow at over 7.9%. The shifting dynamics supporting this growth makes it cri …
  • 世界主要国におけるアガロース市場2017-2022
    The Global Agarose market size will be XX million (USD) in 2022, from the XX million (USD) in 2016, with a CAGR (Compound Annual Growth Rate) XX% from 2016 to 2022. This report studies Agarose in Global market, especially in United States, Canada, Mexico, Germany, France, UK, Italy, Russia, China, J …
※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
※当市場調査資料(GVIEW707423 )"免疫調節剤の世界市場分析:製品別(免疫抑制剤、免疫刺激剤、ワクチン、抗体)、用途別(腫瘍学、呼吸器、HIV)、地域別、セグメント予測、2014-2025" (英文:Immunomodulators Market Analysis By Product (Immunosuppressant, Immunostimulants, Vaccines, Antibodies), By Application (Oncology, Respiratory, HIV), By Region, And Segment Forecasts, 2014-2025 )はGrand View Research社が調査・発行しており、H&Iグローバルリサーチが販売します。


◆H&Iグローバルリサーチのお客様(例)◆


※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
※H&Iグローバルリサーチ(登録第5864124号)及びH&I(登録第5783645号)はH&Iグローバルリサーチ株式会社の商標です。